We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 11,849

Hemp-Derived CBD in Food Products - a Legal Rabbit Hole
  • Wilson Elser
  • USA
  • August 16 2018

CBD, or cannabidiol, is one of more than 100 cannabinoids in the cannabis plant. Unlike tetrahydrocannabinol (THC), CBD is not psychoactive and won’t


BioSig Technologies Receives FDA 510(k) Clearance for Its Noninvasive Electrophysiology Information System
  • Knobbe Martens
  • USA
  • August 16 2018

The Los Angeles-based medical device company BioSig Technologies, Inc. announced in a press release the FDA 510(k) clearance of its PURE EP System


FDA Approves Pfizer’s Biosimilar of Neupogen as Amgen and Pfizer Litigate Patent Infringement
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • August 9 2018

On July 20, 2018, FDA approved Pfizer’s biosimilar of Amgen’s Neupogen (filgrastim). Pfizer’s product, Nivestym, is the second biosimilar of


US pharma companies under increasing legislative pressure, key EU SPC decision and much more in July’s life sciences IP round-up
  • IAM
  • USA
  • August 9 2018

In this month’s round-up of patent news from the life sciences, we report on the latest blow to the St Regis Mohawks’ attempt shield their Restasis


Health Canada invites public comments on new post-market reporting regulations
  • Gowling WLG
  • USA, Canada
  • August 9 2018

The medical device industry in America and perceived shortcomings in the US Food and Drug Administration's ("FDA") approval process have recently come


REMSSharing is so hard to do
  • K&L Gates
  • USA
  • August 9 2018

The U.S. Food and Drug Administration (FDA) recently released two draft guidance documents related to its requirement for shared risk evaluation and


FDA Believes Concentrated Animal Feeding Operation May Be A Cause of Romaine Outbreak
  • Keller and Heckman LLP
  • USA
  • August 8 2018

On July 31 and August 1, 2018, the U.S. Food and Drug Administration (FDA) participated in a meeting of the Leafy Greens Food Safety Task Force that


Be Careful What You Ask For
  • Dechert LLP
  • USA
  • August 7 2018

Today’s post is an update to our post from just a few weeks ago regarding McWilliams v. Novartis AG, No. 2:17-CV-14302 (S.D. Fla.). At that time, the


California Appeals Court Reverses Decision Requiring Proposition 65 Warnings on Cereals for Acrylamide
  • Hogan Lovells
  • USA
  • August 3 2018

A California appeals court has reversed a trial court decision that would require businesses to post Proposition 65 cancer warnings on certain


FDA Holds Public Meeting on Nutrition Innovation Strategy
  • Hogan Lovells
  • USA
  • August 3 2018

On July 26, 2018, the Food and Drug Administration (FDA) held a public meeting to discuss issues related to the agency's comprehensive multi-year